Cargando…
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836692/ https://www.ncbi.nlm.nih.gov/pubmed/33521676 http://dx.doi.org/10.1016/S2665-9913(20)30415-X |
| _version_ | 1783642800424747008 |
|---|---|
| author | Bovijn, Jonas Lindgren, Cecilia M Holmes, Michael V |
| author_facet | Bovijn, Jonas Lindgren, Cecilia M Holmes, Michael V |
| author_sort | Bovijn, Jonas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7836692 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78366922021-01-26 Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply Bovijn, Jonas Lindgren, Cecilia M Holmes, Michael V Lancet Rheumatol Correspondence Elsevier Ltd. 2021-02 2020-12-15 /pmc/articles/PMC7836692/ /pubmed/33521676 http://dx.doi.org/10.1016/S2665-9913(20)30415-X Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Bovijn, Jonas Lindgren, Cecilia M Holmes, Michael V Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply |
| title | Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply |
| title_full | Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply |
| title_fullStr | Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply |
| title_full_unstemmed | Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply |
| title_short | Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply |
| title_sort | genetic il-6r variants and therapeutic inhibition of il-6 receptor signalling in covid-19 – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836692/ https://www.ncbi.nlm.nih.gov/pubmed/33521676 http://dx.doi.org/10.1016/S2665-9913(20)30415-X |
| work_keys_str_mv | AT bovijnjonas geneticil6rvariantsandtherapeuticinhibitionofil6receptorsignallingincovid19authorsreply AT lindgrenceciliam geneticil6rvariantsandtherapeuticinhibitionofil6receptorsignallingincovid19authorsreply AT holmesmichaelv geneticil6rvariantsandtherapeuticinhibitionofil6receptorsignallingincovid19authorsreply |